Oral Chemotherapy and Quality of Care

Study Overview
=================
Brief Summary
-----------------
PARCOURS is a non-interventional research study evaluating dysfunctions in the continuous city-hospital journey of a patients cohort treated by oral chemotherapy (60 patients followed for 3 months). References used are the National Cancer Institute recommendations for the oral chemotherapy treated outpatients. Parameters found are : information exchanged, ambulatory and hospital monitoring in case of adverse event and adherence to treatment. The study includes also a medico-economic evaluation (hospitalization and transport spending in case of dysfunction in the patient's journey). Deviations will be analyzed.

Official Title
-----------------
Community and Hospital Experiences for Patients Treated by Oral Chemotherapy at the University Hospital of Caen: Analysis of the Process and Its Dysfunctions

Conditions
-----------------
Cancer

Intervention / Treatment
-----------------
* Other: Observational


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patient over 18 years old Suffering from cancer (hematological malignancies, digestive tumors, thoracic tumors or cutaneous tumors) With an oral anticancer chemotherapy initial prescription written by an oncologist or hematologist from the University Hospital of Caen, whatever the place of the drug dispensing (Community pharmacy or hospital pharmacy ) Exclusion Criteria: - Patient treated by oral anticancer chemotherapy for another pathology

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: Observational|Evaluation of dysfunctions in the continuous city-hospital journey of a patients cohort treated by oral chemotherapy|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of dysfunctions | Number of dysfunctions objectified during the 3-month follow-up period, by sub-processes of the course | 3 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Drug adherence | measured by Morisky-Green's questionnaire to the patient | 3 months | 
| Drug adherence | measured by Data on the refill of prescriptions with the National Health Insurance, and evaluated according to the Drug Possession Ratio | 3 months | 
| Adverse events | number | 3 months | 
| Expenses related to the use of unplanned hospital care | Expenses related to the use of unplanned hospital care during the follow-up period: number of oncologist consultations, transport spending, emergency rehospitalizations and additional examinations. | 3 months | 
| Satisfaction of the patient | RESOCAN questionnaire | At month 3 | 
| Satisfaction of the caregiver | RESOCAN questionnaire | At month 3 | 
| Satisfaction of the local professionals | RESOCAN questionnaire | At month 3 | 
| Quality of life of patients | QLQC 30 | At month 3 |